Objective To evaluate the efficacy and safety of an oral selective tyrosine kinase 2 (TYK2) inhibitor, deucravacitinib, in patients with active psoriatic arthritis (PsA). Methods In this double-blind, ...

(UroToday.com) In the Rapid Abstract Session on the first day of the American Society for Clinical Oncology (ASCO) Genitourinary Cancer Symposium 2022, Dr. Gao presented results of a phase 1/2 study ...

followed by a phase 2 part of SHR-1501 plus BCG in multiple cohorts: Cohort A: BCG-naïve NMIBC Cohort B: BCG-unresponsive NMIBC (CIS +/- papillary disease) Cohort C: BCG-unresponsive papillary disease ...

Supergiant Games has announced that they are putting the final touches on Hades 2 for its official launch, after more than a ...

While there isn't a 1.0 launch date for Hades 2 just yet, Supergiant Games notes that development is approaching the home stretch.